France Fixes 1997 Medical Spend Growth

20 January 1997

The French government and the CNAM health fund have formally fixed the1997 budget allocation for health care spending on medical treatments, drugs and biological analyses and tests at 261.8 billion francs ($4.88 million), or 43.6% of the global health budget in all sectors of the service (600.2 billion francs). This is a 2% rise over 1996.

The public-sector hospitals' budget has also been fixed, at 254.6 billion francs (4.75 billion francs), up only 0.5% on 1996 (Marketletter January 13). The figure for the private-sector hospitals and clinics remains to be agreed.

While any overshooting of the medical treatment and drug spending growth limit of 2% will involve doctors in financial sanctions, indications are that treatment spending alone has been expanding at a slower rate than this limit, at around 1.3%.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight